Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

PJ Guerin; P Oliaro; S Sundar; M Boelaert; SL Croft; P Desjeux; MK Wasunna; ADM Bryceson

doi:10.1016/S1473-3099(02)00347-X

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

PJ Guerin, P Oliaro, S Sundar, M Boelaert, SL Croft, P Desjeux, MK Wasunna, ADM Bryceson

Research output: Contribution to journal › A1: Web of Science-article › peer-review

Original language	English
Journal	Lancet Infectious Diseases
Volume	2
Issue number	8
Pages (from-to)	494-501
ISSN	1473-3099
DOIs	https://doi.org/10.1016/S1473-3099(02)00347-X
Publication status	Published - 2002

Keywords

B780-tropical-medicine
Protozoal diseases
Leishmaniasis
Visceral
Kala azar
Control strategies
Reservoirs
Early detection
Case management
Vector control
Insecticides
Spraying
DDT
Impregnated bednets
Serology
ELISA
PCR
Treatment
Antimonials
Drug resistance
Second-line drugs
Pentamidine
Adverse effects
Amphotericin B
Drug development
Miltefosine
Sitamaquine
Research
Genomics
Molecular biology

Access to Document

10.1016/S1473-3099(02)00347-X

http://lib.itg.be/pdf/itg/2002/2002lidi0494.pdf

Cite this

@article{e838b281a68646bc94229c564dcc2c6c,

title = "Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda",

keywords = "B780-tropical-medicine, Protozoal diseases, Leishmaniasis, Visceral, Kala azar, Control strategies, Reservoirs, Early detection, Case management, Vector control, Insecticides, Spraying, DDT, Impregnated bednets, Serology, ELISA, PCR, Treatment, Antimonials, Drug resistance, Second-line drugs, Pentamidine, Adverse effects, Amphotericin B, Drug development, Miltefosine, Sitamaquine, Research, Genomics, Molecular biology",

author = "PJ Guerin and P Oliaro and S Sundar and M Boelaert and SL Croft and P Desjeux and MK Wasunna and ADM Bryceson",

note = "ITG-H4A; HEALTH; U-EPID; JIF; DOI; PDF; Reprints-R",

year = "2002",

doi = "10.1016/S1473-3099(02)00347-X",

language = "English",

volume = "2",

pages = "494--501",

journal = "Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier",

number = "8",

}

TY - JOUR

T1 - Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

AU - Guerin, PJ

AU - Oliaro, P

AU - Sundar, S

AU - Boelaert, M

AU - Croft, SL

AU - Desjeux, P

AU - Wasunna, MK

AU - Bryceson, ADM

N1 - ITG-H4A; HEALTH; U-EPID; JIF; DOI; PDF; Reprints-R

PY - 2002

Y1 - 2002

KW - B780-tropical-medicine

KW - Protozoal diseases

KW - Leishmaniasis

KW - Visceral

KW - Kala azar

KW - Control strategies

KW - Reservoirs

KW - Early detection

KW - Case management

KW - Vector control

KW - Insecticides

KW - Spraying

KW - DDT

KW - Impregnated bednets

KW - Serology

KW - ELISA

KW - PCR

KW - Treatment

KW - Antimonials

KW - Drug resistance

KW - Second-line drugs

KW - Pentamidine

KW - Adverse effects

KW - Amphotericin B

KW - Drug development

KW - Miltefosine

KW - Sitamaquine

KW - Research

KW - Genomics

KW - Molecular biology

U2 - 10.1016/S1473-3099(02)00347-X

DO - 10.1016/S1473-3099(02)00347-X

M3 - A1: Web of Science-article

SN - 1473-3099

VL - 2

SP - 494

EP - 501

JO - Lancet Infectious Diseases

JF - Lancet Infectious Diseases

IS - 8

ER -